Hong Kong Stock Movement | Grand Pharma (00512.HK) rises nearly 5%; CBT-001 international multicenter Phase III study meets primary clinical endpoint, significantly controlling pterygium lesions.
Zhitong Finance APP has learned that Grand Pharma (00512.HK) rose nearly 5%. As of press time, it was up 4.2% at HK$4.465, with a turnover of HK$7.1222 million.
Latest
